SCHEMBL7974082

SCHEMBL7974082

Oc1nc(-c2ccccc2)nc2ncn(Cc3ccccc3Cl)c12

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
ALDH1A1 P00352 2/20 0.45
LMNA P02545 2/20 0.45
POLB P06746 1/20 0.45
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ATM Q13315 1/20 0.44
ACP1 P24666 1/20 0.41
PDE5A O76074 1/20 0.40
KDM4C Q9H3R0 1/20 0.39
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NPC1 O15118 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
QPCTL Q9NXS2 1/20 0.36
PHF8 Q9UPP1 1/20 0.36
MAP3K14 Q99558 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985425 0.89 ACP1 (0.42) LMNAPOLBSMN1; SMN2ACP1MEN1
SCHEMBL7975267 0.86 SMN1; SMN2 (0.46) ALDH1A1LMNASMN1; SMN2KMT2ACASP3
SCHEMBL7987222 0.85 PDE4A (0.49) ALDH1A1LMNAPOLBRAB9AATM
SCHEMBL7984788 0.85 CYP11B1 (0.45) L3MBTL1ALDH1A1LMNAPOLBRAB9A
SCHEMBL7991405 0.84 CYP11B1 (0.45) ALDH1A1LMNASMN1; SMN2PDE5AKMT2A
SCHEMBL7984459 0.81 NR1H2 (0.43) ALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL7986521 0.81 CYP11B1 (0.47) L3MBTL1ALDH1A1LMNARAB9ASMN1; SMN2
SCHEMBL7984717 0.81 SMN1; SMN2 (0.46) ALDH1A1LMNAPOLBRAB9ASMN1; SMN2
SCHEMBL7988668 0.80 SMN1; SMN2 (0.44) L3MBTL1ALDH1A1SMN1; SMN2ACP1PDE5A
SCHEMBL7988558 0.80 SMN1; SMN2 (0.43) ALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed